| Literature DB >> 33809803 |
Yolanda Núñez1, Čedomir Radović2, Radomir Savić3, Juan M García-Casco1, Marjeta Čandek-Potokar4, Rita Benítez1, Dragan Radojković3, Miloš Lukić2, Marija Gogić2, María Muñoz1, Luca Fontanesi5, Cristina Óvilo1.
Abstract
This work was aimed at evaluating loin transcriptome and metabolic pathway differences between the two main Serbian local pig breeds with divergent characteristics regarding muscle growth and fatness, as well as exploring nutrigenomic effects of tannin supplementation in Mangalitsa (MA) pigs. The study comprised 24 Mangalitsa and 10 Moravka (MO) males, which were kept under identical management conditions. Mangalitsa animals were divided in two nutritional groups (n = 12) receiving a standard (control) or tannin-supplemented diet (1.5%; MAT). Moravka pigs were fed the standard mixture. All animals were slaughtered at a similar age; 120 kg of average live weight (LW) and loin tissue was used for RNA-seq analysis. Results showed 306 differentially expressed genes (DEGs) according to breed, enriched in genes involved in growth, lipid metabolism, protein metabolism and muscle development, such as PDK4, FABP4, MYOD1 and STAT3, as well as a relevant number of genes involved in mitochondrial respiratory activity (MT-NDs, NDUFAs among others). Oxidative phosphorylation was the most significantly affected pathway, activated in Mangalitsa muscle, revealing the basis of a different muscle metabolism. Also, many other relevant pathways were affected by breed and involved in oxidative stress response, fat accumulation and development of skeletal muscle. Results also allowed the identification of potential regulators and causal networks such as those controlled by FLCN, PPARGC1A or PRKAB1 with relevant regulatory roles on DEGs involved in mitochondrial and lipid metabolism, or IL3 and TRAF2 potentially controlling DEGs involved in muscle development. The Tannin effect on transcriptome was small, with only 23 DEGs, but included interesting ones involved in lipid deposition such as PPARGC1B. The results indicate a significant effect of the breed on muscle tissue gene expression, affecting relevant biological pathways and allowing the identification of strong regulatory candidate genes to underlie the gene expression and phenotypic differences between the compared groups.Entities:
Keywords: Mangalitsa; Moravka; muscle; nutrigenomics; pig; tannins; transcriptomics
Year: 2021 PMID: 33809803 PMCID: PMC8002519 DOI: 10.3390/ani11030844
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
The composition of feed mixtures.
| Ingredients (g/kg) | Mixture I (25–60 kg) | Mixture II (60–120 kg) |
|---|---|---|
| Corn (dry) | 632.7 | 691.5 |
| Wheat flour | 150.0 | 150.0 |
| Soybean meal | 139.0 | 90.0 |
| Sunflower meal | 50.0 | 40.0 |
| Calcium carbonate | 10.0 | 9.0 |
| Dicalcium | 9.0 | 10.0 |
| Salt | 4.3 | 4.5 |
| Premix | 5.0 | 5.0 |
| Energy (MJ/kg) | 13.6 | 13.5 |
| Protein (g/kg) | 147 | 130 |
| Lysine (g/kg) | 6.6 | 5.5 |
Technical validation of RNA-seq by qPCR: genes, logarithm of fold change (log2 FC) (negative values correspond to upregulation in MA group) and statistical significance obtained with both techniques and Pearson correlation (r) between the two used methodologies.
| Gene | MA vs. MO | |||||
|---|---|---|---|---|---|---|
| RNA-Seq | qPCR | Correlation | ||||
| log2 FC | q | log2 FC | p | r | ||
|
| −1.406 | 0.019 | −1.260 | 0.0088 | 0.744 | 0.013 |
|
| −1.661 | 0.001 | −0.980 | 0.0301 | 0.626 | 0.053 |
|
| −1.497 | 0.003 | −1.407 | 0.0001 | 0.724 | 0.018 |
|
| −2.869 | 0.101 | −3.563 | 0.0157 | 0.999 | 2.4 × 10−12 |
|
| −1.185 | 0.065 | −0.711 | 0.0246 | 0.651 | 0.041 |
|
| 1.333 | 0.010 | 0.896 | 0.0091 | 0.824 | 0.003 |
|
| 1.390 | 0.074 | 0.571 | 0.2939 | 0.974 | 1.9 × 10−6 |
|
| 0.642 | 0.070 | 0.432 | 0.1351 | 0.670 | 0.076 |
|
| 2.333 | 0.261 | 1.102 | 0.4670 | 0.877 | 0.0008 |
|
| ||||||
|
| −1.488 | 0.087 | −1.108 | 0.0028 | 0.871 | 0.002 |
|
| −1.392 | 0.000 | −1.447 | 0.0001 | 0.894 | 0.001 |
|
| −1.563 | 0.000 | −1.099 | 0.0510 | 0.888 | 0.001 |
|
| −1.117 | 0.560 | −0.919 | 0.1590 | 0.936 | 0.075 |
|
| 0.948 | 0.007 | 0.503 | 0.1660 | 0.620 | 0.0002 |
|
| 1.266 | 0.581 | 1.088 | 0.1886 | 0.992 | 1.5 × 10−7 |
MA: Mangalitsa; MO: Moravka; MAT: Mangalitsa supplemented with tannins.
Phenotypic differences between breed and diet groups.
| Trait | Least Squares Means | MA vs. MO | MA vs. MAT | ||||
|---|---|---|---|---|---|---|---|
| MA | MO | MAT | SEM |
| SEM |
| |
| Slaughter Age, days | 363.2 | 357.3 | 361.9 | 22.80 | 0.555 | 19.63 | 0.878 |
| Average Daily Gain, g | 318.9 | 366.6 | 306.4 | 13.40 | 0.002 | 10.22 | 0.397 |
| Slaughter Weight, kg | 115.5 | 130.2 | 111.1 | 5.70 | 0.018 | 3.98 | 0.441 |
| Carcass Weight, kg | 89.91 | 103.04 | 85.40 | 4.78 | 0.013 | 3.43 | 0.361 |
|
| |||||||
| Loin Thickness, mm | 57.5 | 63.0 | 54.1 | 3.0 | 0.084 | 1.75 | 0.182 |
| Intramuscular fat percentage, % | 8.55 | 8.15 | 11.66 | 1.56 | 0.801 | 0.99 | 0.037 |
| C14:0, % | 2.20 | 2.18 | 2.25 | 0.07 | 0.787 | 0.05 | 0.459 |
| C15:0, % | 0.03 | 0.03 | 0.03 | 0.01 | 0.826 | 0.00 | 0.509 |
| C16:0, % | 27.92 | 27.77 | 28.60 | 0.50 | 0.762 | 0.34 | 0.166 |
| C16:1, % | 3.95 | 3.22 | 3.80 | 0.21 | 0.002 | 0.12 | 0.332 |
| C17:0, % | 0.18 | 0.22 | 0.16 | 0.03 | 0.324 | 0.02 | 0.571 |
| C18:0, % | 11.09 | 12.25 | 11.64 | 0.33 | 0.003 | 0.18 | 0.044 |
| C18:1, % | 46.91 | 46.53 | 46.54 | 0.71 | 0.597 | 0.40 | 0.513 |
| C18:2, % | 4.96 | 4.89 | 4.40 | 0.48 | 0.894 | 0.31 | 0.221 |
| C20:0, % | 0.18 | 0.20 | 0.23 | 0.01 | 0.064 | 0.03 | 0.343 |
| C18:3n-3, % | 0.18 | 0.19 | 0.14 | 0.03 | 0.720 | 0.02 | 0.130 |
| C20:1, % | 0.71 | 0.85 | 0.71 | 0.05 | 0.007 | 0.02 | 0.958 |
| C20:2, % | 0.36 | 0.42 | 0.36 | 0.04 | 0.147 | 0.02 | 0.872 |
| C20:3n-6, % | 0.62 | 0.67 | 0.57 | 0.11 | 0.603 | 0.08 | 0.657 |
| C20:3n-3, % | 0.03 | 0.03 | 0.07 | 0.01 | 0.592 | 0.04 | 0.376 |
| C22:1+C20:4, % | 0.12 | 0.11 | 0.08 | 0.02 | 0.422 | 0.01 | 0.016 |
MA: Mangalitsa; MO: Moravka; MAT: Mangalitsa supplemented with tannins; n: number of biological replicates.
Figure 1Oxidative phosphorylation pathway predicted to be activated in Mangalitsa, created using Ingenuity Pathway Analysis software (IPA).
Canonical Pathways derived from Ingenuity Pathway Analysis (IPA) in the set of differential expression genes according to breed comparison.
| Ingenuity Canonical Pathways | Uregulated in MA ŧ | Upregulated in MO ŧ | DE Genes | |
|---|---|---|---|---|
| Oxidative Phosphorylation | 0.17 × 10−7 |
| 0/109 (0%) |
|
| Mitochondrial Dysfunction | 0.14 × 10−5 | 11/171 (6%) | 0/171 (0%) |
|
| NER (Nucleotide Excision Repair) Pathway | 0.10 × 10−3 |
| 0/35 (0%) |
|
| Sirtuin Signaling Pathway | 0.14 × 10−3 | 9/291 (3%) | 2/291 (1%) |
|
| Estrogen Receptor Signaling | 0.27 × 10−2 | 5/328 (2%) | 4/328 (1%) |
|
| NRF2-mediated Oxidative Stress Response | 0.36 × 10−2 | 2/189 (1%) | 4/189 (2%) |
|
| Wnt/Ca+ pathway | 0.45 × 10−2 | 2/62 (3%) | 1/62 (2%) |
|
| Protein Ubiquitination Pathway | 0.64 × 10−2 | 6/273 (2%) | 1/273 (0%) |
|
| EIF2 Signaling | 0.69 × 10−2 | 5/223 (2%) | 1/223 (0%) |
|
| Leptin Signaling in Obesity | 0.70 × 10−2 | 2/74 (3%) | 1/74 (1%) |
|
| Glucocorticoid Receptor Signaling | 0.70 × 10−2 | 5/336 (1%) | 3/336 (1%) |
|
| cAMP-mediated signaling | 0.76 × 10−2 | 1/228 (0%) | 5/228 (2%) |
|
| Adipogenesis pathway | 0.95 × 10−2 | 3/134 (2%) | 1/134 (1%) |
|
| HIPPO signaling | 0.97 × 10−2 | 0/85 (0%) | 3/85 (4%) |
|
* Significance values (p-value of overlap) for the canonical pathways are calculated by the right-tailed Fisher’s Exact Test and indicate the probability of association of molecules from the DE dataset with the canonical pathway by random chance alone. ŧ Number of genes upregulated in Mangalitsa (MA) and Moravka (MO) in relation to the total number of genes in the pathway. Bold letters indicate significant activation in one breed predicted by IPA.
Prediction of upstream regulators involved in the gene expression differences between breeds.
| Upstream Regulator | Predicted Activation | Activation z-Score | Target Molecules in Dataset | |
|---|---|---|---|---|
| PDGF BB | Moravka | 2.318 | 2.05 × 10−4 |
|
| NFkB | Moravka | 2.346 | 6.85 × 10−2 |
|
| SIRT3 | Moravka | 2.635 | 1.31 × 10−6 |
|
| RICTOR | Moravka | 2.121 | 2.97 × 10−2 |
|
| IGF1 | Moravka | 2.179 | 1.00 × 10−1 |
|
| EGFR | Moravka | 2.191 | 9.58 × 10−2 |
|
| FOXO1 | Moravka | 2.200 | 3.20 × 10−1 |
|
| MYRF | Moravka | 2.000 | 1.38 × 10−2 |
|
| NR4A1 | Moravka | 2.372 | 7.78 × 10−2 |
|
| BMP6 | Moravka | 2.000 | 3.80 × 10−4 |
|
| FOXO3 | Moravka | 2.200 | 8.70 × 10−2 |
|
| ERBB2 | Moravka | 2.000 | 3.66 × 10−1 |
|
| ALKBH1 | Mangalitsa | −2.000 | 2.12 × 10−6 |
|
| CAB39L | Mangalitsa | −2.000 | 1.63 × 10−3 |
|
| NSUN3 | Mangalitsa | −2.000 | 2.12 × 10−6 |
|
| PPARGC1B | Mangalitsa | −2.236 | 3.65 × 10−4 |
|
| LONP1 | Mangalitsa | −2.646 | 7.80 × 10−5 |
|
| TAL1 | Mangalitsa | −2.000 | 9.89 × 10−3 |
|
| SIRT1 | Mangalitsa | −2.201 | 2.96 × 10−1 |
|
| DAP3 | Mangalitsa | −2.449 | 8.73 × 10−9 |
|
Figure 2Causal network predicted using Ingenuity Pathway Analysis software where FLCN (folliculin, predicted activated in Moravka) regulates PPARGC1A (PPARG coactivator 1 alpha, inhibited in Moravka) which would increase functions involved in lipid metabolism and energy production in Mangalitsa group.
Figure 3Causal network predicted using Ingenuity Pathway Analysis software with IL3 (interleukin 3) as main regulator and enriched biological functions in Moravka breed.
Figure 4Causal network predicted using Ingenuity Pathway Analysis software where PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) is regulator molecule activated in Mangalitsa breed involved, among others, in lipid metabolism functions.
Enriched functions identified using Ingenuity Pathway Analysis software in the set of differentially expressed genes, according to diet.
| Categories | Functions Annotation | Predicted Activation | Activation z-Score | Molecules | |
|---|---|---|---|---|---|
| Cell Death and Survival | Apoptosis | 7.49 × 10−3 | MA | −1.296 |
|
| Organismal Survival | Organismal death | 1.91 × 10−2 | MA | −1.166 |
|
| Cell Death and Survival | Apoptosis of tumor cell lines | 8.54 × 10−3 | MA | −0.588 |
|
| Tissue Morphology | Quantity of cells | 4.57 × 10−2 | MA | −0.532 |
|
| Cellular Development, Connective Tissue Development and Function, Tissue Development | Differentiation of connective tissue cells | 1.15 × 10−4 | MA | −0.045 |
|
| Cellular Development, Cellular Growth and Proliferation | Proliferation of blood cells | 2.47 × 10−2 | MAT | 1.887 |
|
| Cellular Development, Cellular Growth and Proliferation | Colony formation of tumor cell lines | 9.51 × 10−4 | MAT | 1.165 |
|
| Cellular Development, Connective Tissue Development and Function, Tissue Development | Differentiation of bone cells | 8.47 × 10−4 | MAT | 0.988 |
|
| Gene Expression | Activation of DNA endogenous promoter | 6.12 × 10−3 | MAT | 0.981 |
|
| Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | Concentration of lipid | 4.23 × 10−3 | MAT | 0.638 |
|
| Gene Expression | Transcription of RNA | 1.05 × 10−2 | MAT | 0.403 |
|
| Cellular Development, Cellular Growth and Proliferation | Cell proliferation of tumor cell lines | 3.96 × 10−2 | MAT | 0.352 |
|
| Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | Quantity of steroid | 2.87 × 10−3 | MAT | 0.152 |
|
Figure 5Upstream regulator predicted using Ingenuity Pathway Analysis software, where FGR (FGR proto-oncogene, Src family tyrosine kinase) inhibition leads to activation of survival functions and inhibition of apoptosis in the tannin-supplemented Mangalitsa group.